Loading...
Market
Will Aster DM Healthcare become India's top hospital chain by market share by the end of 2026?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Market share reports from healthcare industry analysts
Story
Aster DM Healthcare Merges with Quality Care India, Creating $5 Billion Entity with 10-15% EBITDA Expansion
Dec 2, 2024, 01:15 AM
Aster DM Healthcare has announced a significant merger with Blackstone-backed Quality Care India, creating a combined entity valued at approximately Rs 43,000 crore ($5 billion). The merger will be accretive to earnings per share (EPS) from the first year, according to Alisha Moopen, Deputy Managing Director of Aster DM Healthcare. The deal involves Aster DM acquiring 1.9 crore shares of Quality Care India at Rs 445.8 per share through a share swap agreement. This merger positions Aster DM among India's top three hospital chains and is expected to drive additional EBITDA expansion of 10-15% over the next 24-36 months, with a projected revenue compound annual growth rate (CAGR) for the combined entity. Aster DM's founder-chairman, Dr. Azad Moopen, is also involved in outlining the merger's roadmap and broader expansion plans.
View original story
Similar markets
Yes • 50%
No • 50%
Aster DM leads with over 30% market share • 25%
Aster DM has 20-30% market share • 25%
Aster DM has less than 20% market share • 25%
Data unavailable or inconclusive • 25%
Moopen family retains key leadership roles • 25%
Blackstone appoints new leadership • 25%
TPG appoints new leadership • 25%
Other stakeholders appoint new leadership • 25%
Stock price increases by over 20% • 25%
Stock price increases by 0-20% • 25%
Stock price decreases by 0-20% • 25%
Stock price decreases by over 20% • 25%
Yes • 50%
No • 50%
Increase by more than 5% • 25%
Increase by 1-5% • 25%
No change • 25%
Decrease • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
UnitedHealth gains significant market share • 25%
Amedisys gains significant market share • 25%
Competitors gain significant market share • 25%
No significant change in market share • 25%
Mankind Pharma becomes the largest drug maker • 25%
Mankind Pharma becomes the second largest drug maker • 25%
Mankind Pharma remains the fourth largest drug maker • 25%
Mankind Pharma's ranking declines • 25%
Reliance-Disney leads • 25%
Sony leads • 25%
Netflix leads • 25%
Amazon leads • 25%